HZNP NASDAQ
Horizon Therapeutics Public Limited Company
1W: +0.3%
1M: +0.8%
3M: +12.9%
1Y: +71.3%
3Y: +45.2%
5Y: +513.7%
$116.30
Last traded 2023-10-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$4B
Revenue
-4.4% YoY
$438M
Net Income
-42.7% YoY
$906M
Free Cash Flow
-28.7% YoY
76.7%
Gross Margin
15.1%
Op. Margin
13.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE8.5%
ROA4.8%
ROIC9.4%
Valuation
P/E51.0
P/B5.3
EV/EBITDA25.2
Leverage
Debt/Equity0.48
Current Ratio4.27
Interest Cov.7.5x
Quality Scores
Piotroski F7/9
Altman Z4.70
Beneish M-2.77